Startups
Edit
Fougera Pharmaceuticals, Inc.
http://www.convergencepharma.com/Last activity: 24.09.2014
Active - Reference to Afternic
Acquired by Biogen
Novel analgesics based on state dependent ion channel pharmacology and medicinal chemistry platform.
Cambridge, UK
Novel analgesics based on state dependent ion channel pharmacology and medicinal chemistry platform.
Cambridge, UK
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 5, 2010 | Convergence Pharmaceuticals Raises $35.4M in Series A Financing | Convergence Pharmaceuticals, a Cambridge, UK-based biotechnology company focused on the development of novel analgesics, has received a $35.4m Series A private equity financing. Investors include New Leaf Venture Partners, Apposite Capital ... |
| SF startup gets $1.4M to develop non-opioid pain meds | SiteOne Therapeutics, a San Francisco startup in the pain meds and pain diagnostics arena, has raised $1.5 million in an initial equity round. On top of that, it just secured a $1.4 million Phase II SBIR grant from the NIH. This early fundi... |
Reviews 0
FAQ about Fougera Pharmaceuticals, Inc.
What has the press written about Fougera Pharmaceuticals, Inc.?
Parsers VC has collected 3 articles mentioning Fougera Pharmaceuticals, Inc., among them “Convergence Pharmaceuticals Raises $35.4M in Series A Financing” (Oct 5, 2010) and “SF startup gets $1.4M to develop non-opioid pain meds”.
Is Fougera Pharmaceuticals, Inc. still active?
Yes, Fougera Pharmaceuticals, Inc. is active; its latest activity on Parsers VC dates from Sep 24, 2014.